eBay
EBAY
Halozyme Therapeutics
HALO
Constellation Brands
STZ
4
Workday
WDAY
5
Lantheus
LNTH
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 19.85%1.11B | 10.36%284.7M | 28.50%291.1M | 16.78%267.34M | 25.45%266.6M | 17.95%925.95M | 15.39%257.98M | 18.18%226.53M | 28.87%228.93M | 10.59%212.52M |
Total premiums earned | 21.13%1.01B | 19.03%269.05M | 20.63%258.66M | 22.11%246.94M | 23.11%236.05M | 10.01%834.41M | 17.02%226.03M | 12.90%214.43M | 7.38%202.23M | 2.48%191.74M |
-Net premiums written | 18.17%1.09B | 12.90%255.56M | 16.54%292.61M | 20.40%294.94M | 23.11%236.05M | 19.59%925.3M | 8.62%226.36M | 32.20%251.09M | 30.07%244.97M | 2.48%191.74M |
-Increase decrease in net unearned premium reserves | 9.00%-82.7M | 4,237.12%13.49M | 7.38%-33.96M | -12.28%-47.99M | ---- | -496.72%-90.88M | ---326K | ---36.66M | ---42.74M | ---- |
Net investment income | -47.15%5.15M | -198.65%-10.85M | 217.88%10.5M | -140.70%-2.7M | 689.12%8.2M | 121.50%9.75M | 2.31%11M | 39.75%-8.91M | 123.29%6.62M | 108.07%1.04M |
Net realized gain loss on investments | 481.76%7.72M | 1,381.02%3.2M | 386.67%1.31M | 2,413.89%2.72M | -32.88%492K | -85.56%1.33M | -62.56%216K | -78.42%270K | -96.57%108K | -82.59%733K |
Fee revenue and other income | 14.57%7.94M | 20.92%2.14M | 2.35%1.96M | 15.30%2.03M | 21.92%1.81M | 1,124.73%6.93M | --1.77M | --1.92M | --1.76M | --1.48M |
-Fees and commissions | 14.57%7.94M | 20.92%2.14M | 2.35%1.96M | 15.30%2.03M | 21.92%1.81M | 1,124.73%6.93M | 213.25%1.77M | --1.92M | --1.76M | --1.48M |
Interest income | 6.39%78.22M | 11.60%21.16M | -0.90%18.66M | 0.77%18.35M | 14.41%20.05M | 18.29%73.52M | 2.35%18.96M | 23.14%18.83M | 24.79%18.21M | 27.46%17.53M |
Total expenses | 13.13%1.02B | 13.37%274.58M | 15.24%258.19M | 18.63%246.11M | 5.78%241M | 24.27%901.53M | 26.30%242.19M | 21.83%224.05M | 23.67%207.46M | 25.14%227.82M |
Loss adjustment expense | 11.57%716.64M | 12.14%193.01M | 14.40%182.49M | 20.36%172.74M | 0.75%168.4M | 30.55%642.3M | 30.35%172.11M | 28.57%159.52M | 27.33%143.52M | 35.71%167.15M |
Underwriting expenses | 19.00%305.32M | 18.21%81.27M | 19.40%77.87M | 18.12%73.92M | 20.38%72.27M | 4.66%256.58M | 10.34%68.75M | 8.02%65.22M | 2.81%62.58M | -2.53%60.03M |
Non-operating net interest income (expenses) | 37.78%-509K | -2.48%-124K | 10.79%-124K | 60.34%-138K | 41.43%-123K | -56.11%-818K | 8.33%-121K | -5.30%-139K | -165.65%-348K | -62.79%-210K |
-Interest expense-non operating | -37.78%509K | 2.48%124K | -10.79%124K | -60.34%138K | -41.43%123K | 56.11%818K | -8.33%121K | 5.30%139K | 165.65%348K | 62.79%210K |
Income from associates and other participating interests | 85.40%10.27M | 324.87%1.67M | 79.03%4.35M | 348.46%2.48M | -18.19%1.77M | -55.62%5.54M | -85.97%394K | 177.05%2.43M | -90.73%553K | -23.52%2.17M |
Income before tax | 268.00%89.87M | -35.89%10.12M | 1,228.96%32.91M | -1.08%21.24M | 267.29%25.61M | -59.01%24.42M | -50.37%15.78M | -68.15%2.48M | 117.12%21.47M | -251.34%-15.31M |
Income tax | 245.03%19.13M | -43.55%1.99M | 1,231.31%7.02M | 2.98%4.6M | 286.16%5.53M | -57.41%5.55M | -50.92%3.52M | -66.69%527K | 124.87%4.47M | -230.49%-2.97M |
Earnings from equity interest net of tax | ||||||||||
Net income | 274.75%70.73M | -33.69%8.13M | 1,228.32%25.89M | -2.15%16.64M | 262.75%20.08M | -59.46%18.88M | -50.22%12.26M | -68.52%1.95M | 115.18%17M | -257.40%-12.34M |
Net Income continuous operations | 274.75%70.73M | -33.69%8.13M | 1,228.32%25.89M | -2.15%16.64M | 262.75%20.08M | -59.46%18.88M | -50.22%12.26M | -68.52%1.95M | 115.18%17M | -257.40%-12.34M |
Minority interest income | ||||||||||
Net income attributable to the parent company | 274.75%70.73M | -33.69%8.13M | 1,228.32%25.89M | -2.15%16.64M | 262.75%20.08M | -59.46%18.88M | -50.22%12.26M | -68.52%1.95M | 115.18%17M | -257.40%-12.34M |
Preferred stock dividends | ||||||||||
Other preferred stock dividend | 274.12%318K | -21.82%43K | 1,133.33%111K | -6.41%73K | -58.54%85K | -49.54%55K | -66.67%9K | 116.67%78K | ||
Net income attributable to common stockholders | 274.75%70.42M | -33.74%8.09M | 1,228.76%25.78M | -2.13%16.56M | 262.75%20.08M | -59.47%18.79M | -50.22%12.21M | -68.53%1.94M | 115.17%16.92M | -258.11%-12.34M |
Basic earnings per share | 274.22%4.79 | -33.73%0.55 | 1,238.46%1.74 | -1.74%1.13 | 261.90%1.36 | -59.62%1.28 | -50.60%0.83 | -69.05%0.13 | 112.96%1.15 | -258.49%-0.84 |
Diluted earnings per share | 273.44%4.78 | -33.73%0.55 | 1,230.77%1.73 | -1.74%1.13 | 261.90%1.36 | -59.37%1.28 | -50.30%0.83 | -69.05%0.13 | 116.98%1.15 | -258.49%-0.84 |
Dividend per share | 0.00%3.6 | 0.00%0.9 | 0.00%0.9 | 0.00%0.9 | 0.00%0.9 | 0.00%3.6 | 0.00%0.9 | 0.00%0.9 | 0.00%0.9 | 0.00%0.9 |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- | -- |